ConMed reported 3Q19 revenue of USD $110.3MM, +7.2% vs. 3Q18.
ConMed updated full year 2019 revenue guidance to the range of $951.3MM (+10.7%) to $956.6MM (+11.3%) Growth driven by continuity of leadership and new products integrated with training and education programs Recurring, single-use products comprise 70% of the company’s orthopedic revenue ORTHOWORLD projects ConMed sports medicine full year 2019 revenue of $466.9MM, +4.5% vs. 2018 ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).
3Q19 3Q18 $ Chg % Chg Sports Medicine $110.3 $102.9 $7.4 7.2%
9Mo 19 9Mo 18 $ Chg % Chg Sports Medicine $339.5 $321.9 $17.6 5.5%
ORTHOWORLD estimates orthopedic sales by geographic region as follows ($MM).
3Q19 3Q18 $ Chg % Chg U.S. $42.5 $39.6 $3.0 7.5% Ex-U.S. $67.8 $63.4 $4.4 7% EMEA $24.7 $23.2 $1.5 6.4% Asia Pacific $26.0 $25.2 $0.8 3.3% Rest of World $17.1 $14.9 $2.1 14.2% Total $110.3 $102.9 $7.4 7.2%
Net earnings, inclusive of all ConMed revenue, are as follows ($MM).
Amt % of Sales Sales $233.6 Cost of Sales ($103.5) 44.3% Selling and Admin ($98.2) 42% R&D ($11.0) 4.7% Other ($14.0) 6% Net Earnings $7.0 3%
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email .
Favorite
ConMed reported 3Q19 revenue of USD $110.3MM, +7.2% vs. 3Q18.
ConMed updated full year 2019 revenue guidance to the range of $951.3MM (+10.7%) to $956.6MM (+11.3%)
ConMed reported 3Q19 revenue of USD $110.3MM, +7.2% vs. 3Q18.
ConMed updated full year 2019 revenue guidance to the range of $951.3MM (+10.7%) to $956.6MM (+11.3%) Growth driven by continuity of leadership and new products integrated with training and education programs Recurring, single-use products comprise 70% of the company’s orthopedic revenue ORTHOWORLD projects ConMed sports medicine full year 2019 revenue of $466.9MM, +4.5% vs. 2018 ORTHOWORLD estimates segment sales and growth on an as-reported basis, as follows ($MM).
3Q19 3Q18 $ Chg % Chg Sports Medicine $110.3 $102.9 $7.4 7.2%
9Mo 19 9Mo 18 $ Chg % Chg Sports Medicine $339.5 $321.9 $17.6 5.5%
ORTHOWORLD estimates orthopedic sales by geographic region as follows ($MM).
3Q19 3Q18 $ Chg % Chg U.S. $42.5 $39.6 $3.0 7.5% Ex-U.S. $67.8 $63.4 $4.4 7% EMEA $24.7 $23.2 $1.5 6.4% Asia Pacific $26.0 $25.2 $0.8 3.3% Rest of World $17.1 $14.9 $2.1 14.2% Total $110.3 $102.9 $7.4 7.2%
Net earnings, inclusive of all ConMed revenue, are as follows ($MM).
Amt % of Sales Sales $233.6 Cost of Sales ($103.5) 44.3% Selling and Admin ($98.2) 42% R&D ($11.0) 4.7% Other ($14.0) 6% Net Earnings $7.0 3%
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email .
Favorite You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
